Literature DB >> 325934

Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli.

W Bessler, K Resch, E Hancock, K Hantke.   

Abstract

Lipoprotein from the outer membrane of E. coli, a potent novel mitogen, was digested by pronase treatment resulting in lipopeptide fragments containing 2-5 amino acids bound to diacylglyceryl-N-acylcysteinthioether. The lipopeptides were characterized by amino acid analysis and gas chromatography and were checked for mitogenicity. We found that all lipopeptide fragments were able to stimulate the uptake of 3H-uridine into RNA and 3H-thymidine into DNA in mouse spleen cells of several strains. The response of splenocytes of congenitally athymic mice was comparable to that of normal animals. A weak stimulation of DNA synthesis was also observed in thymocytes. The mitogenicity of the products was abolished by mild alkali hydrolysis which removes the ester-bound fatty acids. We conclude that the N-terminal lipopeptide region of lipoprotein is responsible for the mitogenic activity of the molecule. Lipopeptide as well as lipoprotein were found to cause early membrane changes in lymphocyte plasma membranes. After 4 hours we found an increased incorporation of 14C-oleate and 14C-acetate into lecithin. The membrane changes observed are similar to those brought about by mitogenic lectins, which suggests a similar mechanism for the induction of lymphocyte activation for both types of mitogens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325934

Source DB:  PubMed          Journal:  Z Immunitatsforsch Immunobiol        ISSN: 0340-904X


  12 in total

1.  The 34-kilodalton membrane immunogen of Treponema pallidum is a lipoprotein.

Authors:  M A Swancutt; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Molecular cloning, nucleotide sequence, and characterization of a 40,000-molecular-weight lipoprotein of Haemophilus somnus.

Authors:  M Theisen; C R Rioux; A A Potter
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.

Authors:  Tsugumi Okusawa; Mari Fujita; Jun-Ichiro Nakamura; Takeshi Into; Motoaki Yasuda; Atsutoshi Yoshimura; Yoshitaka Hara; Akira Hasebe; Douglas T Golenbock; Manabu Morita; Yoshio Kuroki; Tomohiko Ogawa; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Antigenic protein modifications in Ehrlichia.

Authors:  S Thomas; N Thirumalapura; E C Crossley; N Ismail; D H Walker
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

5.  Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand.

Authors:  Ada Weinstock; Meirav Pevsner-Fischer; Ziv Porat; Michael Selitrennik; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

6.  Mitogenic effects of purified outer membrane proteins from Pseudomonas aeruginosa.

Authors:  Y H Chen; R E Hancock; R I Mishell
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

7.  Lipoprotein release by bacteria: potential factor in bacterial pathogenesis.

Authors:  H Zhang; D W Niesel; J W Peterson; G R Klimpel
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi.

Authors:  L I Katona; G Beck; G S Habicht
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  A defined fragment of bacterial protein I (OmpF) is a polyclonal B-cell activator.

Authors:  M Vordermeier; K Stäb; W G Bessler
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

10.  Mitogenicity of a lipid-deficient lipoprotein from a mutant Escherichia coli strain.

Authors:  W G Bessler; E Simon; H Rotering
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.